ALLMedicine™ Acute Sinusitis Center

Nov 11th, 2022 - Primary immunodeficiency disorders (PIDDs) may be a risk factor for development of recurrent acute rhinosinusitis (RARS). There are currently no clear guidelines for the timing and methodology of PIDD testing in patients with RARS. The aim of this...

Nov 3rd, 2022 - We describe an unusual presentation of EBV-associated mucocutaneous ulcer presenting as a large tumor of the nasopharynx in an immune suppressed child. This condition is newly characterized and has not been well-studied in the otolaryngology liter...

Oct 28th, 2022 - This study aimed to investigate the change in the incidence and variance of otorhinolaryngologic diseases during the coronavirus disease 19 (COVID-19) pandemic. The entire Korean population (~50 million) was evaluated for the monthly incidence of ...

Oct 12th, 2022 - The current clinical practice guideline from the American Academy of Pediatrics for the Diagnosis and Management of Acute Bacterial Sinusitis recommends that the diagnosis of acute sinusitis is made when symptoms of an upper respiratory infection ...

Aug 27th, 2022 - To assess the efficacy of interruptive electronic alerts in improving adherence to the American Board of Internal Medicine's Choosing Wisely recommendations to reduce unnecessary laboratory testing. We administered 5 cluster randomized controlled ...

Oct 12th, 2022 - The current clinical practice guideline from the American Academy of Pediatrics for the Diagnosis and Management of Acute Bacterial Sinusitis recommends that the diagnosis of acute sinusitis is made when symptoms of an upper respiratory infection ...

Dec 10th, 2021 - The aim of this study is to compare the efficacy and safety of cefpodoxime 200 mg immediate (b.i.d) and cefpodoxime 400 mg modified release (q.d) tablet formulations in the treatment of acute bacterial rhinosinusitis.

Aug 12th, 2021 - Double-blind comparative-effectiveness study of the treatment of acute bacterial sinusitis with standard dose of amoxicillin/clavulanate 875mg/125mg bid for 7 days, as recommended by the Infectious Disease Society of America, with or without the a...

Dec 11th, 2020 - Patients with acute sinusitis were randomly assigned (1:1) to receive either cefetamet (500 mg twice daily, study group) or cefdinir (100 mg three times a day, control group) and corresponding placebo t.i.d. or b.i.d. for 2 weeks.

Sep 30th, 2020 - This is a randomized controlled trial. Patients suffering from recurrent acute sinusitis episodes will be randomly allocated to two groups: intervention group, where they will receive endoscopic sinus surgery in addition to medical treatment and c...

Dec 1st, 2021 - Key clinical point: Sinusitis, pharyngitis, and acute respiratory burden all raised the likelihood of developing rheumatoid arthritis (RA). Major finding: Acute sinusitis (odds ratio [OR], 1.

Apr 22nd, 2021 - (Reuters Health) - A move by the U.S. Food and Drug Administration (FDA) in 2016 to remove systemic quinolones' indication for acute uncomplicated urinary tract infection, acute sinusitis, and acute exacerbation of COPD reduced, but didn't elimina...

Feb 6th, 2020 - How nasal polyps manifest is largely dependent on their size. Small polyps may be asymptomatic and identified only during routine examination when they are anterior to the anterior edge of the middle turbinate. Conversely, small polyps in areas wh...

Jan 17th, 2019 - Almost one quarter (23.2%) of outpatient antibiotic prescriptions in the United States are inappropriate, according to an analysis of new diagnosis codes and insurance claims data from 19.2 million patients. "This study provides the most recent an...

Jan 16th, 2019 - More than 23% of all antibiotic prescriptions filled in 2016 were medically unnecessary, and another 36% were questionable, according to an analysis of prescribing data for 19. 2 million children and nonelderly adults.